We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+13.02%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.44B
AUM Growth
+$120M
Cap. Flow
-$28.9M
Cap. Flow %
-2.01%
Top 10 Hldgs %
46.5%
Holding
136
New
5
Increased
13
Reduced
35
Closed
2

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$1.93M
2
BIO icon
Bio-Rad Laboratories Class A
BIO
+$1.35M
3
INCY icon
Incyte
INCY
+$1.17M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$711K
5
INMD icon
InMode
INMD
+$457K

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$10.1M
2
AMZN icon
Amazon
AMZN
+$8.55M
3
META icon
Meta Platforms (Facebook)
META
+$4.71M
4
SEDG icon
SolarEdge
SEDG
+$2.34M
5
CVSA
Covista Inc
CVSA
+$1.1M

Sector Composition

Rank Sector Weight
1 Technology 45.52%
2 Communication Services 15.06%
3 Healthcare 14.04%
4 Consumer Discretionary 11.21%
5 Financials 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CI icon
26
Cigna
CI
$77B
$16.3M 1.13%
44,801
– –
MA icon
27
Mastercard
MA
$487B
$15.8M 1.1%
32,885
– –
NVS icon
28
Novartis
NVS
$297B
$14.7M 1.02%
152,158
-675
-0.4% -$69.2K
GPN icon
29
Global Payments
GPN
$23B
$13.9M 0.96%
103,662
+2
+0% +$264
LH icon
30
Labcorp
LH
$24.7B
$13.8M 0.96%
63,316
-1,302
-2% -$287K
ALC icon
31
Alcon
ALC
$32.8B
$13.6M 0.94%
163,428
-685
-0.4% -$54.9K
MCK icon
32
McKesson
MCK
$99.5B
$13M 0.9%
24,147
-300
-1% -$152K
QRVO icon
33
Qorvo
QRVO
$7.92B
$11.5M 0.8%
100,007
– –
ZBH icon
34
Zimmer Biomet
ZBH
$17.8B
$11.4M 0.79%
86,273
-490
-0.6% -$61.2K
DOX icon
35
Amdocs
DOX
$5.64B
$11.3M 0.78%
125,137
– –
MCHP icon
36
Microchip Technology
MCHP
$42.3B
$11.1M 0.77%
123,349
– –
CTSH icon
37
Cognizant
CTSH
$22.3B
$10.8M 0.75%
146,863
-907
-0.6% -$69.3K
APH icon
38
Amphenol
APH
$184B
$10.7M 0.74%
186,224
– –
CHKP icon
39
Check Point Software Technologies
CHKP
$13.6B
$9.68M 0.67%
59,008
– –
REGN icon
40
Regeneron Pharmaceuticals
REGN
$69.9B
$9.46M 0.66%
9,826
– –
PFE icon
41
Pfizer
PFE
$141B
$8.31M 0.58%
299,470
– –
LMT icon
42
Lockheed Martin
LMT
$134B
$7.92M 0.55%
17,401
– –
INTC icon
43
Intel
INTC
$462B
$7.88M 0.55%
178,476
+6,809
+4% +$303K
AIZ icon
44
Assurant
AIZ
$13.7B
$7.83M 0.54%
41,603
– –
BNY
45
Bank of New York Mellon
BNY
$107B
$6.31M 0.44%
109,549
+1
+0% +$55
GILD icon
46
Gilead Sciences
GILD
$162B
$6.12M 0.42%
83,583
-692
-0.8% -$53.2K
CRM icon
47
Salesforce
CRM
$142B
$5.48M 0.38%
18,210
– –
AIT icon
48
Applied Industrial Technologies
AIT
$12.9B
$5.01M 0.35%
25,372
– –
STT icon
49
State Street
STT
$50.7B
$4.54M 0.31%
58,741
-682
-1% -$50.6K
PAYX icon
50
Paychex
PAYX
$41.1B
$4.43M 0.31%
36,115
-5
-0% -$607
1
2
3 4 5

Similar funds

FAT
First American Trust Santa Ana, California $1.49B AUM 21.98% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
LFS
Lutz Financial Services Omaha, Nebraska $1.49B AUM 10.4% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.49B AUM 28.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Oak Associates's Q1 2024 Portfolio in Review

As of Q1 2024, Oak Associates held 136 positions worth $1.44B, up 9.1% from $1.32B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Oak Associates's Q1 2024 filing shows 5 new, 13 increased, 35 reduced and 2 closed positions. Its largest new stake was Danaher: 7,920 shares worth $1.98M. The largest sale was Alphabet (Google) Class C, an estimated $10.1M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 45% a quarter earlier, followed by Communication Services and Healthcare.

  • Oak Associates's largest Q1 2024 buy was Danaher: 7,920 shares worth $1.98M.
  • Oak Associates added most to Jazz Pharmaceuticals in Q1 2024, an estimated $711K increase.
  • Oak Associates's biggest Q1 2024 reduction was Alphabet (Google) Class C, cutting an estimated $10.1M.
  • Oak Associates fully exited SolarEdge in Q1 2024, selling an estimated $2.34M.
  • Oak Associates's ten largest holdings make up 47% of its $1.44B portfolio in Q1 2024.
  • Oak Associates opened 5 new positions and closed 2 in Q1 2024.
  • Oak Associates's portfolio value rose 9.1% quarter-over-quarter to $1.44B.

Based on Oak Associates's 13F filing for Q1 2024, filed 10 May 2024.